In 2021, the biosimilars industry in Japan was estimated to stand at around 94.5 billion Japanese yen. The market was forecast to reach approximately 124.2 billion Japanese yen by 2030.
Market size of the biosimilars industry in Japan from 2018 to 2021 with a forecast for 2030 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Spain
Main figures
6
- Basic Statistic Production value of pharmaceutical products & preparations in Spain 2009-2020
- Basic Statistic Turnover of the manufacture of pharmaceutical products in Spain 2009-2020
- Basic Statistic Workers in the Spanish pharmaceutical industry 2008-2020
- Premium Statistic Wages earned in the pharmaceutical industry sector in Spain 2008-2020
- Basic Statistic Spain: number of manufacturers of basic pharmaceutical products 2009-2020
- Basic Statistic Spain: number of pharmaceutical preparations manufacturers 2009-2020
International trade
6
- Premium Statistic Value of pharmaceutical products exported from Spain 2002-2021
- Premium Statistic Value of pharmaceutical products imported by Spain 2002-2021
- Premium Statistic Export value of pharmaceutical products in Spain 2021, by type
- Premium Statistic Import value of pharmaceutical products in Spain 2021, by type
- Premium Statistic Pharmaceutical products export value in Spain 2021, by country of destination
- Premium Statistic Import value of pharmaceutical products in Spain 2021, by country
Pharmaceutical sales
6
- Premium Statistic Net sales of drugs in pharmacies in Spain 2012-2021
- Premium Statistic Net value of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Value share of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Volume of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Volume share of drugs sold in pharmacies by therapeutic group in Spain 2021
- Premium Statistic Average price of drugs sold in pharmacies by therapeutic group in Spain 2021
Pharmaceutical expenditure of the National Health System
6
- Premium Statistic Budget expenditure on health benefits & pharmacy in Spain 2003-2022
- Premium Statistic NHS expenditure on prescribed medicines in pharmacies in Spain 2010-2021
- Premium Statistic Average cost of medical prescriptions in pharmacies in Spain 2010-2021
- Premium Statistic State-funded drug prescriptions dispensed in pharmacies in Spain 2010-2021
- Premium Statistic NHS expenditure per prescription dispensed in pharmacies in Spain 2021, by region
- Premium Statistic Share of per capita pharmaceutical expenditure in Spain 2021, by region
Research and development
6
- Premium Statistic Share of total R&D spending in Spain in 2020, by industrial sector
- Premium Statistic R&D expenditure in the pharmaceutical industry in Spain 2008-2021
- Premium Statistic R&D employment within the pharmaceutical industry in Spain 2008-2021
- Premium Statistic Pharmaceutical R&D spending by type Spain 2021
- Premium Statistic Internal and external R&D expenditure in the pharmaceutical industry Spain 2013-2021
- Premium Statistic External R&D expenditure in the pharmaceutical industry by region Spain 2021
Company rankings
6
- Premium Statistic Leading basic pharmaceutical products manufacturers in Spain in 2020
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2020
- Premium Statistic Leading pharmaceutical goods wholesalers in Spain in 2020
- Premium Statistic Corporate reputation of leading pharmaceutical companies in Spain in 2022
- Premium Statistic Sales value of the largest-selling prescription drugs in Spain 2020
- Premium Statistic Sales volume of the largest-selling prescription drugs in Spain 2019-2020
Further related statistics
17
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Biopharmaceutical market size forecast Japan 2011-2020
- Net result of pharmaceutical companies in Italy 2016-2018
- Market revenue from type 2 diabetes pharmaceuticals by region 2012-2022
- Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Pharma revenue share forecast worldwide for 2060, by country
- Pharma revenue share worldwide 2017, by country
- World pharmaceutical select subsector value share 2017
- Pharmaceutical expenditure forecast worldwide by country 2030
- Operating result of pharmaceutical companies in Italy 2016-2018
- Average price of patented pharmaceuticals in Italy 2010-2021
- Number of employees of pharmaceutical companies in Italy 2016-2018
- Comparison ASP of Remicade vs biosimilars in the U.S. Q3 2020
- Value share of pharma market worldwide 2015 vs. 2021, by subsector
- Factors impacting valuation of biopharma companies per executives 2020
Further Content: You might find this interesting as well
Statistics
- Celltrion R&D investment South Korea 2013-2017
- Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Biopharmaceutical market size forecast Japan 2011-2020
- Net result of pharmaceutical companies in Italy 2016-2018
- Market revenue from type 2 diabetes pharmaceuticals by region 2012-2022
- Average peak sales forecast per new biopharmaceutical asset 2013-2022
- Pharma revenue share forecast worldwide for 2060, by country
- Pharma revenue share worldwide 2017, by country
- World pharmaceutical select subsector value share 2017
- Pharmaceutical expenditure forecast worldwide by country 2030
- Operating result of pharmaceutical companies in Italy 2016-2018
- Average price of patented pharmaceuticals in Italy 2010-2021
- Number of employees of pharmaceutical companies in Italy 2016-2018
- Comparison ASP of Remicade vs biosimilars in the U.S. Q3 2020
- Value share of pharma market worldwide 2015 vs. 2021, by subsector
- Factors impacting valuation of biopharma companies per executives 2020
Fuji Keizai Group. (June 3, 2022). Market size of the biosimilars industry in Japan from 2018 to 2021 with a forecast for 2030 (in billion Japanese yen) [Graph]. In Statista. Retrieved March 28, 2023, from https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/
Fuji Keizai Group. "Market size of the biosimilars industry in Japan from 2018 to 2021 with a forecast for 2030 (in billion Japanese yen)." Chart. June 3, 2022. Statista. Accessed March 28, 2023. https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/
Fuji Keizai Group. (2022). Market size of the biosimilars industry in Japan from 2018 to 2021 with a forecast for 2030 (in billion Japanese yen). Statista. Statista Inc.. Accessed: March 28, 2023. https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/
Fuji Keizai Group. "Market Size of The Biosimilars Industry in Japan from 2018 to 2021 with a Forecast for 2030 (in Billion Japanese Yen)." Statista, Statista Inc., 3 Jun 2022, https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/
Fuji Keizai Group, Market size of the biosimilars industry in Japan from 2018 to 2021 with a forecast for 2030 (in billion Japanese yen) Statista, https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/ (last visited March 28, 2023)
Market size of the biosimilars industry in Japan from 2018 to 2021 with a forecast for 2030 (in billion Japanese yen) [Graph], Fuji Keizai Group, June 3, 2022. [Online]. Available: https://www.statista.com/statistics/827763/japan-biosimilars-market-size-forecast/